Actuate Therapeutics, Inc. Common stock (ACTU) financials · $49.0M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Actuate Therapeutics, Inc. Common stock (ACTU) $49.0M cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Income | -$22.5M | -$25.2M |
| Net Income | -$22.2M | -$27.3M |
| EPS (Diluted) | -$1.06 | -$3.26 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $14.0M | $9.32M |
| Current Assets | $13.6M | $9.21M |
| Cash & Equivalents | $13.2M | $8.64M |
| Total Liabilities | $6.11M | $9.21M |
| Current Liabilities | $5.71M | $8.80M |
| Shareholders' Equity | $7.92M | $104.2K |
| Retained Earnings | -$154.6M | -$132.4M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$19.2M | -$21.8M |
| Financing Cash Flow | $23.7M | $27.5M |
FAQ
What is ACTU P/E and revenue?
Actuate Therapeutics, Inc. Common stock (ACTU) $49.0M cap.
What is ACTU revenue?
ACTU income-statement cache has no revenue figure yet.
Is ACTU profitable?
Actuate Therapeutics, Inc. Common stock last cached net income is -$22.2M (FY2025).
What are ACTU total assets?
Actuate Therapeutics, Inc. Common stock last cached total assets are $14.0M (FY2025).
What is ACTU free cash flow?
No cached cash-flow row for ACTU yet.
Not investment advice. Cached statements, not a live tape.